Patents by Inventor Steve Kay

Steve Kay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for modulating circadian rhythm
    Publication number: 20050186138
    Abstract: The present invention provides methods of identifying circadian rhythm modulators and methods of modulating circadian rhythm in animals.
    Type: Application
    Filed: October 13, 2004
    Publication date: August 25, 2005
    Applicants: IRM, LLC, The Scripps Research Institute
    Inventors: John Hogenesch, Trey Sato, Steve Kay
  • Methods for treating circadian rhythm phase disturbances
    Publication number: 20050149993
    Abstract: The present invention provides a transgenic non-human animals comprising a disruption in the melanopsin gene as well as methods for using the animals to identify agents useful for modulating circadian rhythm in animals.
    Type: Application
    Filed: August 8, 2003
    Publication date: July 7, 2005
    Applicants: IRM LLC, Uniformed Services University of the Health Sciences, The Scripps Research Institute
    Inventors: Satchidananda Panda, John Hogenesch, Ignacio Provincio, Steve Kay
  • Bioluminescent plants and methods of making same
    Publication number: 20050081268
    Abstract: A genetically modified plant cell containing a heterologous nucleotide sequence encoding a bioluminescent polypeptide, which is expressed in amount sufficient to produce at least about 750,000 photons of visible light/mm2/second, is provided, as is a visibly bioluminescent transgenic plant, which contains such a genetically modified plant cell. Also provided is a recombinant nucleic acid molecule, which contains a plant translational enhancer operatively linked to a nucleotide sequence encoding a bioluminescent polypeptide. In addition, methods of producing a genetically modified plant cell that is visibly bioluminescent introducing a transgene encoding a bioluminescent polypeptide into a plant cell, whereby the bioluminescent polypeptide is expressed at a level that produces at least about 750,000 photons of visible light/mm2/second are provided, as are kits containing such visibly bioluminescent compositions.
    Type: Application
    Filed: April 8, 2002
    Publication date: April 14, 2005
    Inventors: Steve Kay, Tina Kuhlmann, Richard Lerner